Evaluation for antiatherogenic efficacy of febuxostat in patients with hyperuricemia
Not Applicable
- Conditions
- Hyperuricemia
- Registration Number
- JPRN-UMIN000009134
- Lead Sponsor
- Department of Medicine and Bioregulatory Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) known allergic reaction by febuxostat 2) severe renal and/or liver disease 3) pregnant women 4) inadequate candidate at a physician's discretion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of carotid atherosclerosis
- Secondary Outcome Measures
Name Time Method serum uric acid levels